CNTX - Wall Street Estimates - Context Therapeutics Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.01

3.23 %

$ 75.7 M

Market Cap

-1.15

P/E

Price Target Average

411.55%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

27.37%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Context Therapeutics Inc.

Wall Street analysts predict an average 1-year price target for CNTX of $5.17 , with forecasts ranging from a low of $4.5 to a high of $6 .

CNTX Lowest Price Target Wall Street Target

4.5 USD 345.54%

CNTX Average Price Target Wall Street Target

5.17 USD 411.55%

CNTX Highest Price Target Wall Street Target

6 USD 494.06%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free